Prediction of LV functional recovery by CMR in myocarditis: Bright signals-bright answers?

European Heart Journal Cardiovascular Imaging

Volumn 15, Issue 10, 2014, Pages 1177-1178

  Buser, Peter T ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN T;

CARDIOVASCULAR MAGNETIC RESONANCE; DIAGNOSTIC ACCURACY; EDITORIAL; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MYOCARDITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; FEMALE; MALE; PATHOPHYSIOLOGY;

FEMALE; HUMANS; MALE; MYOCARDITIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84930166882     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jeu130     Document Type: Editorial

References (11)

1. Blauwet LA, Cooper LT. Myocarditis. Progr Cardiovasc Dis 2010;52:274-88.
2. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT et al. International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009;53:1475-87.
3. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham MEet al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269-75.
4. Grün S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 2012;59:1604-15.
5. McCarthy RE III, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690-5.
6. Schumm J, Greulich S,Wagner A, Grün S, Ong P, Bentz K et al. Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis. J Cardiovasc Magn Reson 2014;16:14.
7. VermesE, Child H, FarisP, FriedrichMG.Predictive value ofCMRcriteria for LVfunctional improvement in patients with acute myocarditis. Eur Heart J Cardiovasc Imaging 2014;15:1140-4.
8. Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, NtusiNet al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging 2013; 6:1048-58.
9. Zagrosek A, Abdel-Aty H, Boyé P,Wassmuth R, Messroghli D, UtzWet al. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2009;2:131-8.
10. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E; Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson 2013;15:91.
11. Francone M, Chimenti C, Galea N, Scopelliti F, Verardo R, Galea R et al. CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. JACC Cardiovasc Imaging 2014;7:254-63.